AUROBINDO PHARMA (AUROPHARMA) - Live BSE, NSE Stock Quotes - AUROBINDO PHARMA Analysis Update - Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA   (AUBD)

REFRESH
Live BSE Quotes Jul 28, 2016 (Close)
Price (Rs)779.20 Open (Rs) 794.00 High (Rs) 798.45 Low (Rs) 776.55
% Change-1.80 Volume 87,515 Value (Rs) 68,762,561 52-Week H/L 891.50 / 582.00
Live NSE Quotes Jul 28, 2016 (Close)
Price (Rs)779.30 Open (Rs) 798.00 High (Rs) 798.00 Low (Rs) 776.05
% Change-1.93 Volume 2,493,588 Value (Rs) 1,956,179,697 52-Week H/L 891.50 / 582.00
Valuation
EPS (Rs)* 35.13 P/E Ratio (x) 22.18 Market Cap (Rs m) 454,211.26 P/BV (x) 8.81
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
AUROBINDO PHARMA Stock Price Chart (Rs) - 1 Year
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new

Related Views On News

Glenmark: Margins under Pressure (Quarterly Results Update - Detailed)

Jun 22, 2016

Glenmark has announced its 4QFY16 results. The company has reported 30.5% YoY growth in sales and 1255.8% YoY increase in net profits. Here is our analysis of the results.

Lupin: Niche products boost business growth (Quarterly Results Update - Detailed)

Jun 15, 2016

Lupin has announced its 4QFY16 results. Net sales have grown by 38.6% YoY, while net profits declined by 54.8% YoY. Here is our analysis of the results.

Cipla: Impacted by one offs (Quarterly Results Update - Detailed)

Jun 2, 2016

Cipla has announced its 4QFY16 results. The company has reported 7.6% YoY growth in sales and a decline of 68.9% YoY in net profits. Here is our analysis of the results.

Biocon: A Good Quarter (Quarterly Results Update - Detailed)

May 10, 2016

Biocon has announced its 4QFY16 and full year results. The company has reported 16.8% YoY growth in total income and 79.1% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: Acquisition synergies start contributing (Quarterly Results Update - Detailed)

Apr 1, 2016

Sun Pharma has announced its 3QFY16 results. Net sales have grown by 2.3% YoY, while net profits surged by 258% YoY. Here is our analysis of the results.

More Views on News

Most Popular

Want to Outperform Markets? Test This.(The 5 Minute Wrapup)

Jul 22, 2016

An undercurrent in Indian stock markets that no one has talked about for years!

Unless Politicians Running APMCs are Kicked Out, Food Inflation will Remain(Vivek Kaul's Diary)

Jul 15, 2016

The farmers need more markets where they can sell their agricultural produce than just APMCs.

Inside the Mind of a Successful Trader(Daily Profit Hunter)

Jul 15, 2016

A successful trader's mindset is to focus on what he can control, and let go of what he can't. This means focusing on trading strategy, and not worrying about what the market does afterwards

Will Realty Prices Fall Soon?(Chart Of The Day)

Jul 19, 2016

Why real estate prices could fall?

A Little Gem in the FMCG Sector(Sector Info)

Jul 18, 2016

Will investing in Bajaj Corp yield high returns on account of a rural revival in sight?

More

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

Detailed Financial Information With Charts

COMPARE AUROBINDO PHARMA WITH

MARKET STATS